Free sample
As of August 2026

Do not paste your global claim onto a Japanese page

ORCA Labs · As of August 2026

Do not paste your global hero claim onto a Japanese page. Japan still restricts how cosmetics and everyday goods may be advertised. A line that is normal in the US or EU can be unlawful here — and Japanese reviewers are usually deciding on a narrower attribute anyway.

Two statutes that still apply in 2026

Cosmetic and quasi-drug advertising in Japan is limited by the Act on Securing Quality, Efficacy and Safety of Products Including Pharmaceuticals and Medical Devices (the Pharmaceuticals and Medical Devices Act). Article 66 prohibits false or exaggerated statements about name, manufacturing method, efficacy, effect or performance — explicitly or by implication. The Ministry of Health, Labour and Welfare still publishes that rule and the related advertising standards as of August 2026.

Separately, the Act against Unjustifiable Premiums and Misleading Representations (the Premiums and Representations Act), administered by the Consumer Affairs Agency, restricts misleading quality and price claims. A 2023 designation made undisclosed advertising (“stealth marketing”) a violation from 1 October 2023. Amendments that took effect on 1 October 2024, including a commitment procedure, remain in force.

This is not legal advice. Clearance belongs with Japanese counsel or a licensed agency. The operational point for a brand team is simpler: the sentence that won in your home market is not, by default, a sentence you can run in Japan.

Reviewers are already telling you a narrower brief

Japanese reviews rarely repeat a global efficacy slogan. They argue about fragrance load in the morning, whether the refill pouch actually stands up, whether the shade matches, whether Japanese-language support exists after purchase. Those are attributes you can usually discuss without importing a medical-sounding claim.

If you start from the home-market hero line and then “soften the translation”, you are still starting from the wrong sentence. Start from the clauses Japanese buyers actually use to decide, then let counsel mark what may be said on-pack and on the landing page.

What ORCA will and will not do

We read the Japanese conversation and hand you the attributes and phrasing in English. We do not certify that a claim is lawful. We do not write finished production copy. Used in that order — evidence first, legal clearance second, creative last — you spend less time arguing about a slogan that Japan was never going to run.

FAQ

Is this legal advice?
No. We point to the statutes that still exist and to how consumers talk. Claim clearance is work for Japanese counsel or a licensed agency.
Does this only apply to cosmetics?
The Pharmaceuticals and Medical Devices Act is strictest for drugs, quasi-drugs, cosmetics and medical devices. The Premiums and Representations Act applies more broadly to consumer representations. Confirm the category before you write the page.
Can you draft Japanese claims that are safe to publish?
No. We deliver message direction and candidate wording grounded in consumer language. Sign-off on what may be published stays with you and your counsel.

Sources